FDA Inspection
Janssen Vaccines, Zweigniederlassung der Cilag GmbH InternationalJanssen Vaccines, Zweigniederlassung der Cilag GmbH International – FDA Inspection, May 29, 2026
Record Details
This FDA Inspection record concerns Janssen Vaccines, Zweigniederlassung der Cilag GmbH International, with an inspection on May 29, 2026, issued by the Office of Inspections and Investigations, covering biologics.
- Inspection Date
- May 29, 2026
- Product Type
- Biologics
View Company Profile
ID · 708b22d4-e740-4973-b27d-f6fef0388562
Inspection Facts
- Inspection number
- 1319900
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Janssen Vaccines, Zweigniederlassung der Cilag GmbH International
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 18, 2023 | Not classified | Office of Inspections and Investigations | |
| December 7, 2012 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 25, 2011 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 23, 2009 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Janssen Vaccines, Zweigniederlassung der Cilag GmbH International
- FDA Inspection 1225784 - 2023-10-18
- FDA Inspection 819593 - 2012-12-07
- FDA Inspection 717283 - 2011-02-25
- FDA Inspection 618252 - 2009-01-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.